Astraea Therapeutics
Phase 1Astraea Therapeutics is a discovery-stage pharmaceutical company, focused on the development of small-molecule therapeutics for the treatment of drug addiction and central nervous system disorders.
Founded
2018
Focus
Small Molecules
About
Astraea Therapeutics is a discovery-stage pharmaceutical company, focused on the development of small-molecule therapeutics for the treatment of drug addiction and central nervous system disorders.
Funding History
2Total raised: $36M
Series A$30MUndisclosedOct 15, 2022
Seed$6MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2018
LocationCambridge, United States
StagePhase 1
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile